Auto Transplant for High Risk or Relapsed Solid or CNS Tumors
Public ClinicalTrials.gov record NCT01505569. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Alkylator-Intense Conditioning Followed by Autologous Transplantation for Patients With High Risk or Relapsed Solid or CNS Tumors
Study identification
- NCT ID
- NCT01505569
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Masonic Cancer Center, University of Minnesota
- Other
- Enrollment
- 44 participants
Conditions and interventions
Conditions
Interventions
- Anti-seizure prophylaxis Drug
- Autologous stem cell infusion Biological
- Busulfan Drug
- Carboplatin Drug
- Etoposide Drug
- G-CSF Biological
- Ifosfamide Drug
- Leukapheresis Procedure
- Melphalan Drug
- Mesna Drug
- Paclitaxel Drug
- Radiation Radiation
- Thiotepa Drug
- Ursodiol Drug
Drug · Biological · Procedure + 1 more
Eligibility (public fields only)
- Age range
- Up to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 19, 2011
- Primary completion
- Jan 31, 2024
- Completion
- Jan 31, 2024
- Last update posted
- Feb 25, 2024
2011 – 2024
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Masonic Cancer Center, University of Minnesota | Minneapolis | Minnesota | 55455 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01505569, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 25, 2024 · Synced May 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01505569 live on ClinicalTrials.gov.